Direct-to-consumer pharmacogenomic testing assessed in a US-based study

1https://www.23andme.com

2 Green RC Farahany NA. Regulation: The FDA is overcautious on consumer genomics. Nature 2014; 505: 286–7.

3Maitland-van der Zee AH, Daly AK, Kamali F Patients benefit from genetics-guided coumarin anticoagulant therapy. Clin Pharmacol Ther 2014; 96: 15–7. http://dx.doi.org/10.1038/clpt.2014.44

4 Gelissen IC McLachlan AJ. The pharmacogenomics of statins. Pharmacol Res 2013. http://dx.doi.org/10.1016/j.phrs.2013.12.002

5 Pirmohamed M. Personalized pharmacogenomics: Predicting efficacy and adverse drug reactions. Ann Rev Genom Hum Genet 2014. http://dx.doi.org/10.1146/annurev-genom-090413-025419